Interleukin-10 and the interleukin-10 receptor

被引:5339
作者
Moore, KW [1 ]
Malefyt, RD
Coffman, RL
O'Garra, A
机构
[1] DNAX Res Inst Mol & Cellular Biol Inc, Dept Mol Biol, Palo Alto, CA 94304 USA
[2] DNAX Res Inst Mol & Cellular Biol Inc, Dept Pharmacol, Palo Alto, CA 94304 USA
[3] DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA
关键词
interferon; inflammation; tolerance; infectious disease; dendritic cell; monocyte; macrophage; T cell; T regulatory cell;
D O I
10.1146/annurev.immunol.19.1.683
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-10 (IL-10), first recognized for its ability to inhibit activation and effector function of T cells, monocytes, and macrophages, is a multifunctional cytokine with diverse effects on most hemopoietic cell types. The principal routine function of IL-10 appears to be to limit and ultimately terminate inflammatory responses. In addition to these activities, IL-10 regulates growth and/or differentiation of B cells, NK cells, cytotoxic and helper T cells, mast cells, granulocytes, dendritic cells, keratinocytes, and endothelial cells. IL-10 plays a key role in differentiation and function of a newly appreciated type of T cell, the T regulatory cell, which may figure prominently in control of immune responses and tolerance in vivo. Uniquely among hemopoietic cytokines, IL-10 has closely related homologs in several virus genomes, which testify to its crucial role in regulating immune and inflammatory responses. This review highlights findings that have advanced our understanding of IL-10 and its receptor, as well as its in vivo function in health and disease.
引用
收藏
页码:683 / 765
页数:83
相关论文
共 684 条
[1]   Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection [J].
Abrahamsohn, IA ;
Coffman, RL .
EXPERIMENTAL PARASITOLOGY, 1996, 84 (02) :231-244
[2]   IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response [J].
Adris, SK ;
Klein, S ;
Jasnis, MA ;
Chuluyan, E ;
Ledda, MF ;
Bravo, AI ;
Carbone, C ;
Chernajovsky, Y ;
Podhajcer, OL .
GENE THERAPY, 1999, 6 (10) :1705-1712
[3]   Generation of plasma cells from peripheral blood memory B cells: Synergistic effect of interleukin-10 and CD27/CD70 interaction [J].
Agematsu, K ;
Nagumo, H ;
Oguchi, Y ;
Nakazawa, T ;
Fukushima, K ;
Yasui, K ;
Ito, S ;
Kobata, T ;
Morimoto, C ;
Komiyama, A .
BLOOD, 1998, 91 (01) :173-180
[4]   Absence of IgD-CD27+ memory B cell population in X-linked hyper-IgM syndrome [J].
Agematsu, K ;
Nagumo, H ;
Shinozaki, K ;
Hokibara, S ;
Yasui, K ;
Terada, K ;
Kawamura, N ;
Toba, T ;
Nonoyama, S ;
Ochs, HD ;
Komiyama, A .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) :853-860
[5]   Role of interleukin 10 in specific immunotherapy [J].
Akdis, CA ;
Blesken, T ;
Akdis, M ;
Wüthrich, B ;
Blaser, K .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :98-106
[6]  
AKRIDGE RE, 1994, J IMMUNOL, V153, P5782
[7]   Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell B cell antibody synthesis [J].
AlJanadi, M ;
AlDalaan, A ;
AlBalla, S ;
AlHumaidi, M ;
Raziuddin, S .
JOURNAL OF CLINICAL IMMUNOLOGY, 1996, 16 (04) :198-207
[8]  
Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
[9]  
2-4
[10]  
ALLIONE A, 1994, CANCER RES, V54, P6022